|
| |
| | | 66548 | | 11.06.2018 | | AstraZeneca AG | | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Imfinzi 120 mg/2.4 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Durvalumabum 120mg / 2.4ml) | L01FF03 | | | 02 | Imfinzi 500 mg/10 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Durvalumabum 500mg / 10ml) | L01FF03 | |
|
|
|
